Suzanne Kolb

5.3k total citations
49 papers, 1.6k citations indexed

About

Suzanne Kolb is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Suzanne Kolb has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 20 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Suzanne Kolb's work include Prostate Cancer Treatment and Research (35 papers), Genetic Associations and Epidemiology (15 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). Suzanne Kolb is often cited by papers focused on Prostate Cancer Treatment and Research (35 papers), Genetic Associations and Epidemiology (15 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). Suzanne Kolb collaborates with scholars based in United States, South Africa and Netherlands. Suzanne Kolb's co-authors include Janet L. Stanford, Elaine A. Ostrander, Ziding Feng, Jonathan L. Wright, Gail P. Jarvik, Mark Gibbs, Leroy Hood, Ellen L. Goode, Lisa Chakrabarti and Erika M. Kwon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer and American Journal of Epidemiology.

In The Last Decade

Suzanne Kolb

48 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Kolb United States 26 944 644 533 366 222 49 1.6k
Rosina T. Lis United States 24 973 1.0× 970 1.5× 173 0.3× 678 1.9× 179 0.8× 51 2.0k
Rong Na China 20 727 0.8× 405 0.6× 212 0.4× 219 0.6× 104 0.5× 108 1.3k
Zsofia Kote‐Jarai United Kingdom 31 1.3k 1.4× 1.4k 2.2× 1.1k 2.0× 649 1.8× 364 1.6× 92 3.0k
David Dearnaley United Kingdom 18 591 0.6× 478 0.7× 178 0.3× 264 0.7× 80 0.4× 21 1.3k
Akira Komiya Japan 29 1.4k 1.5× 943 1.5× 243 0.5× 492 1.3× 273 1.2× 99 2.4k
Sergey Orlov Russia 21 1.0k 1.1× 804 1.2× 148 0.3× 293 0.8× 136 0.6× 149 2.0k
Xiangtian Kong United States 15 1.2k 1.3× 830 1.3× 304 0.6× 351 1.0× 48 0.2× 20 1.8k
Eijiro Nakamura Japan 19 472 0.5× 512 0.8× 147 0.3× 241 0.7× 100 0.5× 59 1.4k
Yongmei Chen United States 26 1.5k 1.6× 757 1.2× 118 0.2× 566 1.5× 93 0.4× 96 2.4k
Kiyoshi Fujinami Japan 19 442 0.5× 549 0.9× 114 0.2× 208 0.6× 93 0.4× 45 1.2k

Countries citing papers authored by Suzanne Kolb

Since Specialization
Citations

This map shows the geographic impact of Suzanne Kolb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Kolb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Kolb more than expected).

Fields of papers citing papers by Suzanne Kolb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Kolb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Kolb. The network helps show where Suzanne Kolb may publish in the future.

Co-authorship network of co-authors of Suzanne Kolb

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Kolb. A scholar is included among the top collaborators of Suzanne Kolb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Kolb. Suzanne Kolb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hendrix, Nathaniel, Kathryn P. Lowry, Joann G. Elmore, et al.. (2022). Radiologist Preferences for Artificial Intelligence-Based Decision Support During Screening Mammography Interpretation. Journal of the American College of Radiology. 19(10). 1098–1110. 12 indexed citations
2.
Wang, Xiaoyu, Catherine S. Grasso, Kristina M. Jordahl, et al.. (2020). Copy number alterations are associated with metastatic-lethal progression in prostate cancer. Prostate Cancer and Prostatic Diseases. 23(3). 494–506. 11 indexed citations
3.
Dai, James Y., Xiaoyu Wang, Wei Sun, et al.. (2020). DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs. PLoS Genetics. 16(3). e1008667–e1008667. 14 indexed citations
4.
Dai, James Y., Xiaoyu Wang, Anqi Cheng, et al.. (2018). Vigorous Physical Activity Is Associated with Lower Risk of Metastatic–Lethal Progression in Prostate Cancer and Hypomethylation in the CRACR2A Gene. Cancer Epidemiology Biomarkers & Prevention. 28(2). 258–264. 22 indexed citations
5.
Zhao, Shanshan, Milan S. Geybels, Amy Leonardson, et al.. (2016). Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer. Clinical Cancer Research. 23(1). 311–319. 57 indexed citations
6.
Rubicz, Rohina, Irene M. Shui, Shanshan Zhao, et al.. (2015). Health disparities in prostate cancer: Tumor epigenome profiling in African American vs European American men.
7.
Stott‐Miller, Marni, Shanshan Zhao, Jonathan L. Wright, et al.. (2014). Validation Study of Genes with Hypermethylated Promoter Regions Associated with Prostate Cancer Recurrence. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1331–1339. 30 indexed citations
8.
FitzGerald, Liesel M., Akash Kumar, Evan A. Boyle, et al.. (2013). Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility. Cancer Epidemiology Biomarkers & Prevention. 22(9). 1520–1528. 29 indexed citations
9.
Holt, Sarah K., Suzanne Kolb, Rong Fu, et al.. (2013). Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis. Cancer Epidemiology. 37(5). 666–670. 35 indexed citations
10.
Stott‐Miller, Marni, Danielle M. Karyadi, Tiffany Smith, et al.. (2012). HOXB13 mutations in a population‐based, case–control study of prostate cancer. The Prostate. 73(6). 634–641. 40 indexed citations
11.
Kwon, Erika M., Sarah K. Holt, Rong Fu, et al.. (2012). Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk. Cancer Epidemiology. 36(4). 347–353. 38 indexed citations
12.
Lin, Daniel W., Liesel M. FitzGerald, Rong Fu, et al.. (2011). Genetic Variants in the LEPR , CRY1 , RNASEL , IL4 , and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality. Cancer Epidemiology Biomarkers & Prevention. 20(9). 1928–1936. 55 indexed citations
13.
Kwon, Erika M., Claudia A. Salinas, Suzanne Kolb, et al.. (2011). Genetic Polymorphisms in Inflammation Pathway Genes and Prostate Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 20(5). 923–933. 49 indexed citations
14.
Stanford, Janet L., Shannon K. McDonnell, Danielle M. Friedrichsen, et al.. (2005). Prostate cancer and genetic susceptibility: A genome scan incorporating disease aggressiveness. The Prostate. 66(3). 317–325. 36 indexed citations
15.
Peters, Mette A., Marta Janer, Suzanne Kolb, et al.. (2001). Germline mutations in the p73 gene do not predispose to familial prostate‐brain cancer. The Prostate. 48(4). 292–296. 25 indexed citations
16.
Gibbs, Mark, Janet L. Stanford, Gail P. Jarvik, et al.. (2000). A Genomic Scan of Families with Prostate Cancer Identifies Multiple Regions of Interest. The American Journal of Human Genetics. 67(1). 100–109. 79 indexed citations
17.
Gibbs, Mark, et al.. (1999). Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer. UCL Discovery (University College London). 2 indexed citations
18.
Jarvik, Gail P., Janet L. Stanford, Ellen L. Goode, et al.. (1999). Confirmation of Prostate Cancer Susceptibility Genes Using High-Risk Families. JNCI Monographs. 1999(26). 81–87. 10 indexed citations
19.
Gibbs, Mark, Janet L. Stanford, Richard McIndoe, et al.. (1999). Evidence for a Rare Prostate Cancer–Susceptibility Locus at Chromosome 1p36. The American Journal of Human Genetics. 64(3). 776–787. 256 indexed citations
20.
Iro, H., et al.. (1987). [Significance of percutaneous endoscopically controlled gastrostomy in the prevention and therapy of esophagotracheal fistula following long-term intubation].. PubMed. 22(6). 283–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosina T. Lis Breakdown of academic impact, for papers by Rong Na Breakdown of academic impact, for papers by Zsofia Kote‐Jarai Breakdown of academic impact, for papers by David Dearnaley Breakdown of academic impact, for papers by Akira Komiya Breakdown of academic impact, for papers by Sergey Orlov Breakdown of academic impact, for papers by Xiangtian Kong Breakdown of academic impact, for papers by Eijiro Nakamura Breakdown of academic impact, for papers by Yongmei Chen Breakdown of academic impact, for papers by Kiyoshi Fujinami
Rankless by CCL
2026